CK

Chandan Kumar Nishad

Active Director Director DIN 07360031
DIN 07360031 First appointment Jan 2016 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Chandan Kumar Nishad

Data last updated:

Chandan Kumar Nishad is a Director at Tosmed Pharma Private Limited (since 2023) and Director at Danxia Pharmaceutical Private Limited (since 2016). The companies operate in Pharma.

DIN 07360031
Primary Designation Director
Industry Pharma
First Appointment 19 Jan 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tosmed Pharma Private Limited U46596DL2023PTC412209
Director10 Apr 20232023Active
Director19 Jan 20162016Active

Board colleagues of Chandan Kumar Nishad

Directorship timeline

Open interactive timeline →
Tosmed Pharma Private Limited
Danxia Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Chandan Kumar Nishad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandan Kumar Nishad

Chandan Kumar Nishad currently holds 2 directorships: Tosmed Pharma Private Limited (Director, since 10 Apr 2023); Danxia Pharmaceutical Private Limited (Director, since 19 Jan 2016).

Chandan Kumar Nishad was first appointed on 19 Jan 2016 as Director at Danxia Pharmaceutical Private Limited. The most recent appointment on record is 10 Apr 2023 at Tosmed Pharma Private Limited.

The current boards of Chandan Kumar Nishad's companies include Deepak Kumar (Tosmed Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available